Dec. 19, 2024

The bipartisan U.S. House Task Force on Artificial Intelligence (AI) released its highly anticipated report on AI Dec. 17. The nonbinding report is intended to inform policymaking activities and priorities of the next Congress and covers a broad range of cross-cutting and sector-specific issues, including those related to the healthcare sector. The American College of Radiology® (ACR®) met with congressional offices and provided comments in May to inform the task force’s efforts.

In general, the task force supports leveraging and expanding the authorities of existing regulatory agencies within the specific sectors instead of creating a centralized AI agency. With regard to healthcare, the task force recommends:

  • Ensuring AI safety/transparency, particularly for AI that denies or approves care/coverage.
  • Supporting the National Institutes of Health and other agencies’ research into healthcare AI.
  • Creating incentives to ensure appropriate risk management practices.
  • Exploring the expansion of U.S. Food and Drug Administration authority to add to post-market monitoring capabilities.
  • Examining relevant liability laws and standards.
  • Supporting appropriate payment mechanisms.

For more information about ACR’s AI-related programs and initiatives, visit the ACR Data Science Institute website. For questions about AI oversight policy, contact Michael Peters, ACR Senior Director, Government Affairs.

Related ACR News

  • ACR Recommends US Visa Flexibility for Healthcare Workers

    ACR urges DHS to implement flexibility for healthcare workers, streamline extensions, expand Conrad 30, and collaborate with the medical community.

    Read more
  • New Resource Empowers ACR Members to Shape Medicare Policy

    ACR’s CAC Network empowers members to help shape Medicare policy, boost radiology’s voice, and advance patient care through national advocacy.

    Read more
  • ACR Supports Radiation Oncology Case Rate (ROCR) Legislation

    ACR reaffirmed support for ROCR (H.R.2120/S.1031) to protect access to high quality radiation therapy cancer services.

    Read more